FDA Inspection 906071 — Konsyl Pharmaceuticals Inc

Konsyl Pharmaceuticals Inc — FEI 1119033

The FDA completed an inspection of Konsyl Pharmaceuticals Inc on Nov 21, 2014 in Easton, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 21, 2014
Fiscal Year
2015
Product Type
Devices
Project Area
Compliance: Devices
Location
Easton, MD (United States)

Citations

IDCFRDescription
311821 CFR 820.75(a)Documentation
312321 CFR 820.80(c)Lack of or inadequate In-process acceptance procedures
323521 CFR 820.72(a)Equipment control activity documentation